SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-023044
Filing Date
2024-04-29
Accepted
2024-04-29 16:43:18
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20024296x3_defa14a.htm DEFA14A 9947
2 ny20024296x3_nc01.jpg GRAPHIC 381145
3 ny20024296x3_nc02.jpg GRAPHIC 187537
  Complete submission text file 0001140361-24-023044.txt   794765
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34079 | Film No.: 24891931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)